Taking into consideration the results presented here and the fact that testosterone actions via the classical AR are essential for spermatogenesis, the specific targeting of the ZIP9 androgen binding site with the tetrapeptides used in the current study in combination with testosterone treatment might prove to be useful in the treatment of BTB-related male infertility. Here, SLC39A9 is linked to male infertility.